Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Anna Schwendeman
Medical College of Wisconsin, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
EVOQ Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The project involves the use of U-M technology optioned/licensed to the Company. As a co-founder with equity interests, board of directors member, and manager of the Company, Dr. Schwendeman and the Company have the potential to benefit financially through the further development and enhancements of the U-M technology through its use in the research.
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
PROJECT NARRATIVE EGFR is one of the primary driver oncoproteins in lung cancer. The goal of this proposal is to demonstrate the efficacy and mechanisms of combinatorial chemoimmunoprevention approaches, including RXR agonists, multi-peptide EGFR vaccination, and immune checkpoint blockade to prevent EGFR-driven lung tumorigenesis and recurrence. This work will provide the ?proof-of-principle? that will guide future clinical applications for lung cancer prevention.
Filed on April 30, 2019.
Tell us what you know about Anna Schwendeman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Anna Schwendeman”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Anna Schwendeman | Medical College of Wisconsin | Conflict of Interest | EVOQ Therapeutics, LLC | $0 - $4,999 |
| Anna Schwendeman | Medical College of Wisconsin | Conflict of Interest | EVOQ Therapeutics, LLC | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.